Loading
SBC Medical Group Holdings Inc Stock: price and insider trades · United States
US·Mcap US$426.8M
No insider purchase over the last 90 days. The latest, by ZUU Co. Ltd., was filed 02 Aug 2024.
SBC Medical Group Holdings Inc: what insiders have been doing
SBC Medical Group Holdings Inc is a listed company. Filings by its managers are published through SEC (Form 4). From 18 October 2025 to 18 October 2026, the disclosure feed for SBC Medical Group Holdings Inc logged 3 filings by 1 insider.
There is no open-market purchase to report; the filings show 3 sales worth €17.3M by 1 insider. The largest single trade was a sale of €8.1M by Aikawa Yoshiyuki, published on 10 March 2026.
Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify.
With 3 filings in twelve months, the company is quieter than the median of 22 filings across the 5,458 companies we follow on the same exchange. Our records for SBC Medical Group Holdings Inc go back to 2023, with 28 purchases and 5 sales on the open market in total.
Other companies in the same market with recent insider buying flagged by our signals: GameStop Corp. and Heico Corp. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Insider Decl.
37
Thresholds
n/a
Buy Volume
€8M
28 ops. · all time
Sell Volume
€18M
5 ops. · all time
Who traded when
BuySaleYoshiyuki Aikawa3 sales
Analyst consensus: bullish or bearish?
Analysts rate SBC Medical Group Holdings Inc Strong Buy (bullish), based on 4 analysts. Average price target: US$8.50.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 561 of 24,166 companies
83.2
score / 100
Value81
Quality85
FCF yld5.1%
Earn yld12%
EV/EBITDA5.6x
ROE19%
Gross mgn73%
Net mgn29%
Debt/EBITDA0.6x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
US$4.15
Analyst consensus
4 analystsStrong buy
US$7.00Target US$8.50(+105%)US$10.00
Income statement
RevenueUS$173.6M
Gross profitUS$127.3M73% margin
EBITDAUS$84.9M49% margin
Net incomeUS$51M28.0% margin
Valuation
PER (trailing)8.3x
PER (forward)7.7x
P/Book1.6x
Beta0.59
Balance sheet & cash
Market capUS$426.8M
Total debtUS$51.6M
Free Cash FlowUS$22M
Debt / Equity17%
Profitability & ownership
ROE18.9%
ROA11.3%
% insiders81.5%
% institutions4.4%
Last declaration on 29 April 2026
Declarations37 total
465,000 shares@ US$3.02250.43% mcap7.0% of flowCommon StockSEC:0001493152-26-019703:0
3,100,000 shares@ US$3.02252.88% mcap46.2% of flowCommon StockSEC:0001493152-26-018813:0
4,422,900 shares@ US$2.1246.8% of flowCommon StockSEC:0001493152-26-009608:0
15,000 shares0Common Stock, par value $0.0001 per shareSEC:0001213900-24-083384:0
1,503,473 shares0Common Stock, par value $0.0001 per shareSEC:0001140361-24-041498:0
1,503,473 shares0Common Stock, par value $0.0001 per shareSEC:0001213900-24-079606:0
4,755 shares@ US$11.382.3% of flowClass A Common StockSEC:0001140361-24-038427:0
70,000 shares@ US$11.448933.6% of flowClass A Common StockSEC:0001140361-24-037998:0
12 shares@ US$12.500.0% of flowClass A Common StockSEC:0001140361-24-035591:0
Canonical exit: 29 Oct 2024 (T+90)
10,685 shares@ US$13.005.9% of flowClass A Common StockSEC:0001140361-24-034469:0
Canonical exit: 22 Oct 2024 (T+90)
5,404 shares@ US$13.003.0% of flowClass A Common StockSEC:0001140361-24-033659:0
Canonical exit: 15 Oct 2024 (T+90)
3 shares@ US$13.000.0% of flowClass A Common StockSEC:0001140361-24-033341:0
Canonical exit: 10 Oct 2024 (T+90)
5 shares@ US$13.000.0% of flowClass A Common StockSEC:0001140361-24-032967:0
Canonical exit: 7 Oct 2024 (T+90)
30 shares@ US$13.000.0% of flowClass A Common StockSEC:0001140361-24-032536:0
Canonical exit: 30 Sept 2024 (T+90)
2 shares@ US$13.000.0% of flowClass A Common StockSEC:0001140361-24-032046:0
Canonical exit: 25 Sept 2024 (T+90)
1,500 shares@ US$13.000.8% of flowClass A Common StockSEC:0001140361-24-029623:0
Canonical exit: 4 Sept 2024 (T+90)
6 shares@ US$13.000.0% of flowClass A Common StockSEC:0001140361-24-028897:0
Canonical exit: 29 Aug 2024 (T+90)
789 shares@ US$13.000.4% of flowClass A Common StockSEC:0001140361-24-027763:0
Canonical exit: 21 Aug 2024 (T+90)
1 shares@ US$13.000.0% of flowClass A Common StockSEC:0001140361-24-026929:0
Canonical exit: 14 Aug 2024 (T+90)
190 shares@ US$13.000.1% of flowClass A Common StockSEC:0001140361-24-026317:0
Canonical exit: 11 Aug 2024 (T+90)
1 shares@ US$13.000.0% of flowClass A Common StockSEC:0001140361-24-025527:0
Canonical exit: 6 Aug 2024 (T+90)
47 shares@ US$13.000.0% of flowClass A Common StockSEC:0001140361-24-024145:0
Canonical exit: 29 Jul 2024 (T+90)
2,615 shares@ US$12.96791.5% of flowClass A Common StockSEC:0001140361-24-022151:0
Canonical exit: 22 Jul 2024 (T+90)
1 shares@ US$12.800.0% of flowClass A Common StockSEC:0001140361-24-019438:0
Canonical exit: 8 Jul 2024 (T+90)
2 shares@ US$12.800.0% of flowClass A Common StockSEC:0001140361-24-018707:0
Canonical exit: 3 Jul 2024 (T+90)
25 of 37 declarations
About SBC Medical Group Holdings Inc
SBC Medical Group Holdings Inc is a company listed on the XNAS market. It is involved in the medical sector, although further details about its specific activities are not provided.
Recent ranked signals on the same market
Purchases our model currently ranks for the recommendations list.
All recommendations
